
|Articles|September 2, 2002
- Pharmaceutical Technology-09-02-2002
- Volume 26
- Issue 9
Attack Mounts on Drug Prices
Author(s)Jill Wechsler
Congress debates legislation for a Medicare drug benefit while the industry expresses concerns about import control, drug counterfeiting, and patent rights.
Advertisement
Articles in this issue
over 23 years ago
Innovations of Membrane Chromatography for Biomolecular Purificationover 23 years ago
New Syringe Designs Combine Prefilled Convenience with Safetyover 23 years ago
Outsourcing Outlookover 23 years ago
Spreading of Semisolid Formulations: An Updateover 23 years ago
Auditing Your ContractorNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Industry Outlook 2026: Trends Transitioning from 2025 into 2026
2
Amgen Acquires UK Biotech Dark Blue Therapeutics
3
Navigating Financial and Opportunity Risks in Accelerated Drug Launches
4
Behind the Headlines Episode 31: Optimism, Opportunity, Optimization of COGs & Organizational Streamlining
5




